CASE REPORT
Published on 25 Nov 2022
Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review
doi 10.3389/fonc.2022.973421
- 2,215 views
- 4 citations
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy in Specific Patients with Lung Cancer
Immunotherapy in Specific Patients with Lung Cancer
73k
Total downloads
186k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 18 Nov 2022
Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
doi 10.3389/fonc.2022.979384
- 1,062 views
- 3 citations
ORIGINAL RESEARCH
Published on 31 Oct 2022
The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
doi 10.3389/fimmu.2022.956982
- 2,037 views
- 15 citations
ORIGINAL RESEARCH
Published on 27 Oct 2022
Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer
doi 10.3389/fimmu.2022.989968
- 3,233 views
- 8 citations
ORIGINAL RESEARCH
Published on 20 Oct 2022
Immunophenotyping of pulmonary sarcomatoid carcinoma
doi 10.3389/fimmu.2022.976739
- 1,914 views
- 19 citations
ORIGINAL RESEARCH
Published on 27 Sep 2022
Efficacy of immune checkpoint inhibitor therapy in EGFR mutation-positive patients with NSCLC and brain metastases who have failed EGFR-TKI therapy
doi 10.3389/fimmu.2022.955944
- 1,905 views
- 8 citations
ORIGINAL RESEARCH
Published on 17 Aug 2022
Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans
doi 10.3389/fimmu.2022.807915
- 3,354 views
- 4 citations
CASE REPORT
Published on 16 Aug 2022
The time window for the reversal of depigmentation from aggravation to recovery in a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: A case report
doi 10.3389/fimmu.2022.946829
- 2,054 views
ORIGINAL RESEARCH
Published on 05 Aug 2022
Features of patients with advanced EGFR-mutated non-small cell lung cancer benefiting from immune checkpoint inhibitors
doi 10.3389/fimmu.2022.931718
- 2,291 views
- 7 citations
REVIEW
Published on 28 Jul 2022
Research Progress on the Microenvironment and Immunotherapy of Advanced Non-Small Cell Lung Cancer With Liver Metastases
doi 10.3389/fonc.2022.893716
- 2,065 views
- 8 citations
REVIEW
Published on 22 Jul 2022
Immunotherapy for EGFR-mutant advanced non-small-cell lung cancer: Current status, possible mechanisms and application prospects
doi 10.3389/fimmu.2022.940288
- 11,649 views
- 17 citations
ORIGINAL RESEARCH
Published on 01 Jul 2022
Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment
doi 10.3389/fimmu.2022.916284
- 3,079 views
- 6 citations
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 186kTopic views
- 110kArticle views
- 73kArticle downloads